The 5 analysts offering 1 year price forecasts for SHANGHAI MICROPORT ENDOVASCULAR MED have a max estimate of 150.00 and a min estimate of 86.00.
Analyst rating
Based on 8 analysts giving stock ratings to SHANGHAI MICROPORT ENDOVASCULAR MED in the past 3 months.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong buy
5
Buy
2
Hold
1
Sell
0
Strong sell
0
EPS
Forecast
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
0.00
0.40
0.80
1.20
1.60
Reported
Estimate
Currency: CNY
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Reported
1.44
0.95
0.87
1.06
1.04
1.22
—
—
Estimate
1.21
1.08
0.85
1.19
1.24
1.50
1.21
—
Surprise
+19.41%
−12.20%
+3.36%
−10.95%
−16.13%
−18.87%
—
—
Revenue
Forecast
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
0.00
150.00 M
300.00 M
450.00 M
600.00 M
Reported
Estimate
Currency: CNY
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Reported
336.00 M
267.00 M
299.00 M
358.00 M
429.00 M
182.00 M
—
—
Estimate
296.13 M
265.72 M
342.83 M
323.06 M
382.60 M
376.04 M
534.59 M
—
Surprise
+13.46%
+0.48%
−12.78%
+10.82%
+12.13%
−51.60%
—
—
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
We've gathered opinions of 8 analysts rating 688016 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.